Evidence map›Paper›PMID 22378744›Full record

ArticleAmerican journal of physiology. Cell physiology2012

Modulation of Kv1.3 channels by protein kinase A I in T lymphocytes is mediated by the disc large 1-tyrosine kinase Lck complex.

Zerrin Kuras, Vladimir Kucher, Scott M Gordon, Lisa Neumeier, Ameet A Chimote, Alexandra H Filipovich, Laura Conforti

Abstract readComparative Study
In one paragraph

Article in American journal of physiology. Cell physiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Beyond TCR Signaling: Emerging Functions of Lck in Cancer and Immunotherapy.International journal of molecular sciences · 2019
    Review
  8. Dlg1 Maintains Dendritic Cell Function by Securing Voltage-Gated KJournal of immunology (Baltimore, Md. : 1950) · 2019
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Zerrin KurasDepartment of Internal Medicine, 231 Albert Sabin Way, University of Cincinnati, Cincinnati, OH 45267-0585, USA.
Vladimir Kucher
Scott M Gordon
Lisa Neumeier
Ameet A Chimote
Alexandra H Filipovich
Laura Conforti
Center for Cancer and Blood Disorders · USUniversity of Cincinnati · US

Funding

Hypoxia and Potassium Channel Activity in T LymphocytesR01CA095286 · NCI · UNIVERSITY OF CINCINNATI · PI CONFORTI, LAURA · 2003 to 2019
$4.1M
Potassium Channel Trafficking in Geometrically Patterned Immunological SynapsesR21AI083076 · NIAID · UNIVERSITY OF CINCINNATI · PI CONFORTI, LAURA · 2009 to 2010
$427k
NCI NIH HHS 2R01-CA-095286NCI NIH HHS R01 CA095286NIAID NIH HHS 1R21-AI-083076PHS HHS AHA-0855457D
6 · The paper itself

Abstract

The cAMP/PKA signaling system constitutes an inhibitory pathway in T cells and, although its biochemistry has been thoroughly investigated, its possible effects on ion channels are still not fully understood. K(V)1.3 channels play an important role in T-cell activation, and their inhibition suppresses T-cell function. It has been reported that PKA modulates K(V)1.3 activity. Two PKA isoforms are expressed in human T cells: PKAI and PKAII. PKAI has been shown to inhibit T-cell activation via suppression of the tyrosine kinase Lck. The aim of this study was to determine the PKA isoform modulating K(V)1.3 and the signaling pathway underneath. 8-Bromoadenosine 3',5'-cyclic monophosphate (8-BrcAMP), a nonselective activator of PKA, inhibited K(V)1.3 currents both in primary human T and in Jurkat cells. This inhibition was prevented by the PKA blocker PKI(6-22). Selective knockdown of PKAI, but not PKAII, with siRNAs abolished the response to 8-BrcAMP. Additional studies were performed to determine the signaling pathway mediating PKAI effect on K(V)1.3. Overexpression of a constitutively active mutant of Lck reduced the response of K(V)1.3 to 8-Br-cAMP. Moreover, knockdown of the scaffolding protein disc large 1 (Dlg1), which binds K(V)1.3 to Lck, abolished PKA modulation of K(V)1.3 channels. Immunohistochemistry studies showed that PKAI, but not PKAII, colocalizes with K(V)1.3 and Dlg1 indicating a close proximity between these proteins. These results indicate that PKAI selectively regulates K(V)1.3 channels in human T lymphocytes. This effect is mediated by Lck and Dlg1. We thus propose that the K(V)1.3/Dlg1/Lck complex is part of the membrane pathway that cAMP utilizes to regulate T-cell function.

Indexed as

8-Bromo Cyclic Adenosine MonophosphateAdaptor Proteins, Signal TransducingCells, CulturedCyclic AMP-Dependent Protein Kinase Type IDiscs Large Homolog 1 ProteinHumansImmunosuppressive AgentsJurkat CellsKv1.3 Potassium ChannelLymphocyte Specific Protein Tyrosine Kinase p56(lck)Membrane ProteinsSignal TransductionT-Lymphocytes8-Bromo Cyclic Adenosine MonophosphateAdaptor Proteins, Signal TransducingCyclic AMP-Dependent Protein Kinase Type IDiscs Large Homolog 1 ProteinDLG1 protein, humanImmunosuppressive AgentsKv1.3 Potassium ChannelLymphocyte Specific Protein Tyrosine Kinase p56(lck)Membrane Proteins

Identifiers

PMID22378744
PMCPMC3362003
OpenAlexW2019716221

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.